Wells Fargo’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $27.3M | Buy |
973,000
+902,800
| +1,286% | +$24M | 0.01% | 1303 |
|
|
2025
Q4 | $1.75M | Hold |
70,200
| – | – | ﹤0.01% | 3551 |
|
|
2025
Q3 | $1.79M | Buy |
70,200
+68,700
| +4,580% | +$1.7M | ﹤0.01% | 3391 |
|
|
2025
Q2 | $36.4K | Sell |
1,500
-3,214,200
| -100% | -$75M | ﹤0.01% | 5611 |
|
|
2025
Q1 | $81.5M | Sell |
3,215,700
-526,900
| -14% | -$13.8M | 0.02% | 606 |
|
|
2024
Q4 | $99.3M | Buy |
3,742,600
+3,118,300
| +499% | +$84.6M | 0.02% | 539 |
|
|
2024
Q3 | $18.1M | Buy |
624,300
+491,700
| +371% | +$14.3M | ﹤0.01% | 1368 |
|
|
2024
Q2 | $3.71M | Sell |
132,600
-1,135,400
| -90% | -$31.3M | ﹤0.01% | 2493 |
|
|
2024
Q1 | $35.2M | Buy |
1,268,000
+1,206,500
| +1,962% | +$33.5M | 0.01% | 915 |
|
|
2023
Q4 | $1.77M | Sell |
61,500
-1,000
| -2% | -$30.2K | ﹤0.01% | 3007 |
|
|
2023
Q3 | $2.07M | Sell |
62,500
-29,300
| -32% | -$1.04M | ﹤0.01% | 2787 |
|
|
2023
Q2 | $3.37M | Buy |
91,800
+4,400
| +5% | +$171K | ﹤0.01% | 2477 |
|
|
2023
Q1 | $3.57M | Buy |
87,400
+64,700
| +285% | +$2.79M | ﹤0.01% | 2384 |
|
|
2022
Q4 | $1.16M | Sell |
22,700
-10,600
| -32% | -$508K | ﹤0.01% | 3156 |
|
|
2022
Q3 | $1.46M | Sell |
33,300
-917,015
| -96% | -$44.6M | ﹤0.01% | 2976 |
|
|
2022
Q2 | $49.8M | Buy |
950,315
+3,415
| +0.4% | +$174K | 0.02% | 674 |
|
|
2022
Q1 | $49M | Buy |
946,900
+254,785
| +37% | +$13.2M | 0.01% | 796 |
|
|
2021
Q4 | $40.9M | Sell |
692,115
-51,300
| -7% | -$2.54M | 0.01% | 870 |
|
|
2021
Q3 | $32M | Buy |
743,415
+393,000
| +112% | +$17.4M | 0.01% | 1335 |
|
|
2021
Q2 | $13.7M | Buy |
350,415
+305,400
| +678% | +$11.9M | ﹤0.01% | 1968 |
|
|
2021
Q1 | $1.63M | Sell |
45,015
-55,600
| -55% | -$1.97M | ﹤0.01% | 3874 |
|
|
2020
Q4 | $28K | Sell |
100,615
-92,704
| -48% | -$3.4M | ﹤0.01% | 5765 |
|
|
2020
Q3 | $63K | Buy |
193,319
+157,046
| +433% | +$5.51M | ﹤0.01% | 5425 |
|
|
2020
Q2 | $44K | Buy |
36,273
+4,637
| +15% | +$158K | ﹤0.01% | 5524 |
|
|
2020
Q1 | $53K | Sell |
31,636
-4,637
| -13% | -$158K | ﹤0.01% | 5317 |
|
|
2019
Q4 | $150K | Buy |
36,273
+3,056
| +9% | +$109K | ﹤0.01% | 5118 |
|
|
2019
Q3 | $216K | Sell |
33,217
-12,860
| -28% | -$468K | ﹤0.01% | 4921 |
|
|
2019
Q2 | $86K | Buy |
46,077
+45,217
| +5,258% | +$1.8M | ﹤0.01% | 5374 |
|
|
2019
Q1 | $2K | Sell |
860
-53,438
| -98% | -$2.14M | ﹤0.01% | 5870 |
|
|
2018
Q4 | $112K | Buy |
54,298
+1,687
| +3% | +$70K | ﹤0.01% | 5228 |
|
|
2018
Q3 | $100K | Buy |
52,611
+31,830
| +153% | +$1.23M | ﹤0.01% | 5357 |
|
|
2018
Q2 | $14K | Sell |
20,781
-94,016
| -82% | -$3.21M | ﹤0.01% | 5897 |
|
|
2018
Q1 | $23K | Buy |
114,797
+9,802
| +9% | +$337K | ﹤0.01% | 5777 |
|
|
2017
Q4 | $24K | Buy |
104,995
+17
| +0% | +$580 | ﹤0.01% | 5750 |
|
|
2017
Q3 | $87K | Buy |
+104,978
| New | +$3.37M | ﹤0.01% | 5287 |
|
|
2017
Q1 | – | Sell |
-59,762
| Closed | -$18K | – | 6449 |
|
|
2016
Q4 | $18K | Buy |
59,762
+316
| +0.5% | +$9.65K | ﹤0.01% | 5658 |
|
|
2016
Q3 | $39K | Hold |
59,446
| – | – | ﹤0.01% | 5395 |
|
|
2016
Q2 | $53K | Buy |
59,446
+1,476
| +3% | +$47.1K | ﹤0.01% | 5174 |
|
|
2016
Q1 | $213K | Sell |
57,970
-843,200
| -94% | -$24.1M | ﹤0.01% | 4374 |
|
|
2015
Q4 | $1.14M | Buy |
+901,170
| New | +$28.3M | ﹤0.01% | 3402 |
|
|
2015
Q3 | – | Sell |
-843
| Closed | -$1K | – | 6381 |
|
|
2015
Q2 | $1K | Buy |
+843
| New | +$27.5K | ﹤0.01% | 6246 |
|
|
2014
Q3 | – | Sell |
-1,054
| Closed | -$1K | – | 6298 |
|
|
2014
Q2 | $1K | Sell |
1,054
-632
| -37% | -$18K | ﹤0.01% | 6021 |
|
|
2014
Q1 | $1K | Hold |
1,686
| – | – | ﹤0.01% | 5778 |
|
|
2013
Q4 | $3K | Buy |
1,686
+1,054
| +167% | +$30.7K | ﹤0.01% | 5485 |
|
|
2013
Q3 | $2K | Sell |
632
-317
| -33% | -$8.63K | ﹤0.01% | 5453 |
|
|
2013
Q2 | $3K | Buy |
+949
| New | +$26.2K | ﹤0.01% | 5318 |
|
Other funds holding PFE
VCM
VPM
Wells Fargo's PFE Position: Q1 2026 in Review
Wells Fargo increased its Pfizer (PFE) stake by 4.5% in Q1 2026, buying an estimated $22.2M and bringing the position to 19,533,309 shares worth $548M. The position accounts for 0.1% of the portfolio, ranked #191.
Wells Fargo first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.76B in Q3 2018. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Wells Fargo held 19,533,309 shares of Pfizer worth $548M as of Q1 2026.
- Wells Fargo bought 834,673 Pfizer shares in Q1 2026, an estimated $22.2M.
- Pfizer made up 0.1% of Wells Fargo's portfolio in Q1 2026, its #191 holding.
- Wells Fargo first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Wells Fargo's Pfizer position peaked at $1.76B in Q3 2018.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.